Psychedelic-Assisted Therapy in Clinical Practice
August 30, 2024 DOI: 10.64239/pi-vl8205 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review |
|---|---|
| Intervention | Psychedelic-assisted therapy |
| Topics | Psychedelic-assisted therapy |
| Key findings | Psychedelic-assisted therapy's paradigm poses challenges including high costs, scalability issues, and philosophical differences with the biomedical model. |
Abstract
Psychedelic-assisted therapy involves preparation sessions, a supportive psychedelic session, and integration sessions to reinforce therapeutic insights. Psychological safety is a primary concern with psychedelics, and challenging experiences are managed through non-directive support rather than pharmacological intervention. Psychedelic-assisted therapy's unique paradigm poses challenges, including high costs, scalability issues, and philosophical differences with the biomedical model.